Alpna Seth (Nura Bio)
Three years after leaving Biogen, Alpna Seth takes the spotlight with $73M for her neuro startup
When Alpna Seth returned to the US from Europe in 2017 — where she was tasked with setting up Biogen’s biosimilars business from the ground up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
